Prostate-Specific Antigen Screening Should Not Be Covered by Publicly Funded Health Insurance-Reply

JAMA Oncol. 2023 Jun 1;9(6):868-869. doi: 10.1001/jamaoncol.2023.0257.

Authors

Shuang Hao¹, Tobias Nordström¹, Mark S Clements¹

Affiliation

¹ Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

PMID: 37052900
DOI: 10.1001/jamaoncol.2023.0257

No abstract available

Publication types

Comment

MeSH terms

Humans
Insurance, Health*
Male
Medically Uninsured
Prostate-Specific Antigen*

Substances

Prostate-Specific Antigen